MiDx Ltd
Biotechnology Research
Nottingham, Nottinghamshire 59 followers
Redefining rapid point of care microbial diagnostics
About us
MiDx uses unique biomarkers produced by microbes for detection in clinical samples. These biomarkers are present in multiple biofluids allowing for non-microbial containing samples to be used in a POC device. Our lead product uses unique biomarkers for Pseudomonas aeruginosa to detect this bacterium in multiple biofluids (blood, plasma, urine and saliva). This is of particular importance in respiratory infections in people with chronic disease e.g. Cystic fibrosis, where new modulator therapies have markedly changed the production of sputum meaning sputum culture is exceptional challenging.
- Website
-
www.mi-dx.com
External link for MiDx Ltd
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Nottingham, Nottinghamshire
- Type
- Privately Held
- Founded
- 2023
Locations
-
Primary
University Park
Nottingham, Nottinghamshire NG7 2RD, GB
Employees at MiDx Ltd
-
Hayden Jeffreys
Experienced Executive and NED with a portfolio of companies in the Diagnostic and Life Science markets
-
Miguel Camara
Prof. of Molecular Microbiology, Co-Director of the National Biofilms Innovation Centre and CSO of MiDx Ltd
-
Shaun Robertson
Microbial Diagnostics ǀ Research commercialisation ǀ Biofilms ǀ
-
Simone Lucanto
Master graduate in Molecular Biology